Ach-Imatinib 400 mg

Imatinib 400 mg tablets are a medication used to treat certain types of cancer and other conditions. This oral tablet is manufactured by Accord Healthcare Inc. in Canada.

Imatinib 400 mg tablets are primarily used in the management of specific types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This medication works by targeting certain proteins in the body to slow or stop the growth of cancer cells. Imatinib is also used for other conditions where similar protein activity is involved.

Common effects of Imatinib 400 mg tablets may include nausea, vomiting, muscle cramps, and swelling in the legs or ankles. Some individuals may also experience fatigue, diarrhea, or skin rashes. These effects can vary in severity and may not affect everyone who takes the medication.

Imatinib 400 mg tablets should be handled with care and stored as directed. It is important to follow the guidance of a healthcare provider regarding the use of this medication. Pregnant women or those planning to become pregnant should discuss the use of Imatinib with their healthcare provider due to potential risks.

Imatinib 400 mg tablets may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided as they can affect the metabolism of Imatinib.